U of C research finds common acne drug can be used to treat multiple sclerosis
CALGARY — When Jill was 27, she woke up with tingling and numbness in her left hand that eventually spread to half her body.
The Calgary woman, who did not want her last name used for fear it could hinder her future employment, went for tests and was told there was a possibility she would develop multiple sclerosis, a disease of the central nervous system.
Jill was enrolled two months later in a clinical trial led by University of Calgary researchers studying whether minocycline, a common acne drug, could be a more affordable treatment for those in the early stages of MS.
“I was happy in this case to help in any way I could,” said Jill, now 34. “It was an easy decision for me personally.”